Skip to Main Content

Author Details

Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
0000-0001-8333-6607
1997
197
50
PMIDPaper TitleJournal TitlePublished Year
36264026Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia.Br J Haematol2023
37756525Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.Blood2023
38014233Identification of Cellular Interactions in the Tumor Immune Microenvironment Underlying CD8 T Cell Exhaustion.bioRxiv2023
37521042Biology-inspired graph neural network encodes reactome and reveals biochemical reactions of disease.Patterns (N Y)2023
37698624Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.Blood Cancer Discov2023
37782657Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation.PLoS Pathog2023
36976323Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.Mol Cancer Res2023
37361575Immune cell proportions correlate with clinicogenomic features and <i>ex vivo</i> drug responses in acute myeloid leukemia.Front Oncol2023
36441905Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.Blood Adv2023
33375770Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia.Haematologica2022
37552730Community-Based SARS-CoV-2 Testing Using Saliva or Nasopharyngeal Swabs to Compare the Performance of Weekly COVID-19 Screening to Wastewater SARS-CoV-2 Signals.ACS ES T Water2022
35710794Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.Nat Commun2022
35343367Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib.Cancer Biol Ther2022
35499387Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia.Mol Cancer Ther2022
36448288Biology and medicine in the landscape of quantum advantages.J R Soc Interface2022
35939700Targeted RNA editing in brainstem alleviates respiratory dysfunction in a mouse model of Rett syndrome.Proc Natl Acad Sci U S A2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
36307214Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.Cold Spring Harb Mol Case Stud2022
35296646Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma.Cell Death Dis2022
35078224Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia.Blood Adv2022
34780648MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.Blood2022
34482403Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.Blood2022
33414172Serine-Threonine Kinase TAO3-Mediated Trafficking of Endosomes Containing the Invadopodia Scaffold TKS5α Promotes Cancer Invasion and Tumor Growth.Cancer Res2021
33656476Incorporating Immunoproteins in the Development of Classification Models of Progression of Intracranial Hemorrhage After Traumatic Brain Injury.J Head Trauma Rehabil2021
33513210Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.PLoS Pathog2021
33893179Correlation of Regulatory T Cell Numbers with Disease Tolerance upon Virus Infection.Immunohorizons2021
33780043A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance.Am J Hematol2021
34789871Reporting guidelines for human microbiome research: the STORMS checklist.Nat Med2021
34568834Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia.Blood Cancer Discov2021
34301758Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations.Cancer Res2021
34013261Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.bioRxiv2021
33984508Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profiling.Neurobiol Dis2021
34318300Antibody-Free Mass Spectrometry Identification of Vascular Integrity Markers in Major Trauma.Neurotrauma Rep2021
34171263The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance.Cancer Cell2021
31621854Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.J Infect Dis2020
31840818Chronic Voluntary Ethanol Drinking in Cynomolgus Macaques Elicits Gene Expression Changes in Prefrontal Cortical Area 46.Alcohol Clin Exp Res2020
33123685Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia.Nat Cancer2020
32995791Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection.bioRxiv2020
32988967AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-x<sub>L</sub>, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.Clin Cancer Res2020
32843430Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma.Cold Spring Harb Mol Case Stud2020
32668243In Vivo Repair of a Protein Underlying a Neurological Disorder by Programmable RNA Editing.Cell Rep2020
32391790Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.Elife2020
32165999Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma.Oncotarget2020
32513686Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.Proc Natl Acad Sci U S A2020
32348764Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross.Cell Rep2020
32315394Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms.Blood2020
32366937ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia.Leukemia2020
30642575Predicting response to BET inhibitors using computational modeling: A BEAT AML project study.Leuk Res2019
31784538Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.Nat Commun2019
31779979What do functional genomics tell us about pathogenesis of AML?Best Pract Res Clin Haematol2019
  • 1 - 50 of 197

Recommended Authors

Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Career Start Year 2009
Number of shared co-authors 3
Joshua W K Ho
The University of Hong Kong
Career Start Year 2006
Number of shared co-authors 1
Maria Chikina
University of Pittsburgh
Career Start Year 2005
Number of shared co-authors 5
Bin Zhang
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 7
Stephen A Ramsey
Oregon State University
Career Start Year 2004
Number of shared co-authors 7
Zhandong Liu
Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital
Career Start Year 2003
Number of shared co-authors 4
Mark Reimers
Institute for Quantitative Health Science and Engineering, Michigan State University
Career Start Year 2002
Number of shared co-authors 6
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 17
Mikhail G Dozmorov
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 5
Jean Yee Hwa Yang
The University of Sydney
Career Start Year 2001
Number of shared co-authors 1
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 6
David K Crossman
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 1
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 2
Cory C Funk
Institute for Systems Biology
Career Start Year 1999
Number of shared co-authors 9
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 38
Christina Kendziorski
University of Wisconsin-Madison
Career Start Year 1999
Number of shared co-authors 16
Eric E Schadt
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 117
Ralf Herwig
Max Planck Institute for Molecular Genetics
Career Start Year 1998
Number of shared co-authors 1
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 21
Wolfgang Huber
Technische Universitat Munchen
Career Start Year 1995
Number of shared co-authors 11
Paul Pavlidis
University of British Columbia
Career Start Year 1994
Number of shared co-authors 3
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 19
Jill P Mesirov
University of California San Diego
Career Start Year 1992
Number of shared co-authors 17
Winston Hide
Harvard Medical School
Career Start Year 1991
Number of shared co-authors 52
Robert Gentleman
Center for Computational Biomedicine, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 21
Andreas Beyer
University of Cologne
Career Start Year 1991
Number of shared co-authors 2
John Quackenbush
Harvard T. H. Chan School of Public Health
Career Start Year 1989
Number of shared co-authors 28
Michael F Ochs
The College of New Jersey
Career Start Year 1988
Number of shared co-authors 9
Yuval Kluger
Yale University School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 13

Collaborators

Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 45
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 44
Beth Wilmot
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 40
Robert Hitzemann
Portland Alcohol Research Center, Oregon Health and Science University
Co-authored papers 37
Brian J Druker
Oregon Health & Science University
Co-authored papers 34
Sophia Jeng
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 30
Michael A Mooney
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 22
Priscila Darakjian
Oregon National Primate Research Center
Co-authored papers 19
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 19
Ovidiu D Iancu
Oregon Health & Science University
Co-authored papers 18
Nicole A R Walter
Oregon National Primate Research Center, Oregon Health & Science University
Co-authored papers 17
Robert P Searles
Oregon Health & Science University
Co-authored papers 17
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 15
Ralph S Baric
University of North Carolina
Co-authored papers 15
John K Belknap
Oregon Health & Science University
Co-authored papers 15
Martin T Ferris
University of North Carolina.
Co-authored papers 14
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 13
Christina L Zheng
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 12
Lisa E Gralinski
University of North Carolina at Chapel Hill
Co-authored papers 12
Denesa Oberbeck
Oregon Health & Science University
Co-authored papers 12
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 12
Nicola Long
Oregon Health and Science University
Co-authored papers 11
Fernando Pardo-Manuel de Villena
University of North Carolina
Co-authored papers 11
Ted Laderas
Oregon Health & Science University
Co-authored papers 10
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 10
Bill H Chang
Oregon Health and Science University
Co-authored papers 10
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 10
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 9
Guanming Wu
Oregon Health and Science University
Co-authored papers 9
Tamilla Nechiporuk
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 9
Release 1.2